Since COX2 is overexpressed in approximately 80% of colorectal cancers (CRCs) (20), we chose CRC as a model and we took advantage of two different approaches, both able to modulate the intracellular heme content. The gene discussed is PTGS2; the disease is colorectal carcinoma.